Mesa Laboratories Inc (MLAB)
Mesa Laboratories, Inc. is a Lakewood, Colorado-based company incorporated in 1982 and listed on NASDAQ under the ticker MLAB. The company develops, manufactures, sells, and services life sciences tools and quality control products used in healthcare, pharmaceutical, medical device, laboratory, and related industrial settings across North America, Europe, the Asia Pacific, and other international markets.
Its operations are organized into several segments. Sterilization and Disinfection Control provides biological, chemical, and cleaning indicators, along with testing and laboratory services, to help evaluate sterilization, disinfection, and cleaning processes. Clinical Genomics offers the MassARRAY genetic analysis system and related consumables for applications including inherited disease testing, pharmacogenetics, oncology, infectious disease, and research use. Biopharmaceutical Development supplies automated protein-analysis systems, peptide synthesis instruments, and peptide purification products. Calibration Solutions provides measurement and calibration products for environmental and process monitoring, dialysis, gas flow, air quality, and torque testing under brands such as DialyGuard, ViewPoint, DataTrace, DryCal, and BGI.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-MLAB
|
$105.04
|
7.7% Upside
|
Fair
|
$112
|
14.8% Upside
|
Fair
|
Good
|
August 31, 2026
|
September 15, 2026
|
0.64
|
0.7%
|
August 12, 2026
|
80.7x
|
2.9x
|
2.2x
|
534.1 M
|
682 M
|
24.0%
|
87.9%
|
2.0
|
52.5%
|
589.7%
|